Across the recent three months, 6 analysts have shared their insights on ResMed RMD, expressing a variety of opinions spanning from bullish to bearish. The following table provides a quick ...

Consequently, the margin between the parallel market and NAFEM rate narrowed to N13.41 per dollar from N20.73 per dollar on Tuesday.

ResMed shares soared amid an upbeat outlook for sleep apnea treatments, while Insulet shares jumped following a new FDA approval. Shares of Paramount Global fell after media executive Edgar ...

ResMed's management isn't just brushing off the threat of weight loss drugs — it's doubling down on the theory that they'll benefit the company's sleep apnea business. 'We believe that the growth in ...

Investors need to buy shares before the ex-dividend date to gain access to that dividend. For Resmed, the shares will go ex-dividend on 8 May 2024, which is next Wednesday. That means investors ...